<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediators Inflamm</journal-id><journal-id journal-id-type="publisher-id">MI</journal-id><journal-title>Mediators of Inflammation</journal-title><issn pub-type="ppub">0962-9351</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1155/2007/31986</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Study</subject></subj-group></article-categories><title-group><article-title>Serum Leptin Levels in Patients with Ocular and Nonocular Beh&#x000e7;et's Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yal&#x000e7;&#x00131;nda&#x0011f;</surname><given-names>F. Nil&#x000fc;fer</given-names></name><xref rid="a1" ref-type="aff"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>K&#x00131;sa</surname><given-names>&#x000dc;&#x000e7;ler</given-names></name><xref rid="a2" ref-type="aff"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bat&#x00131;o&#x0011f;lu</surname><given-names>Figen</given-names></name><xref rid="a1" ref-type="aff"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yal&#x000e7;&#x00131;nda&#x0011f;</surname><given-names>Ali</given-names></name><xref rid="a2" ref-type="aff"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>&#x000d6;zdemir</surname><given-names>&#x000d6;zden</given-names></name><xref rid="a1" ref-type="aff"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>&#x000c7;a&#x0011f;layan</surname><given-names>Osman</given-names></name><xref rid="a2" ref-type="aff"><sup>2</sup></xref></contrib></contrib-group><aff id="a1"><sup>1</sup>Department of Ophthalmology, Faculty of Medicine, Ankara University, 06100 Ankara, Turkey</aff><aff id="a2"><sup>2</sup>Department of Clinical Biochemistry, Faculty of Medicine, K&#x00131;r&#x00131;kkale University, 71200 K&#x00131;r&#x00131;kkale, Turkey</aff><author-notes><corresp id="cor1">*F. Nil&#x000fc;fer Yal&#x000e7;&#x00131;nda&#x0011f;: <email>yalcinda@medicine.ankara.edu.tr</email></corresp></author-notes><pub-date pub-type="ppub"><year>2007</year></pub-date><pub-date pub-type="epub"><day>15</day><month>5</month><year>2007</year></pub-date><volume>2007</volume><elocation-id>31986</elocation-id><history><date date-type="received"><day>9</day><month>2</month><year>2007</year></date><date date-type="accepted"><day>13</day><month>3</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 F. Nil&#x000fc;fer Yal&#x000e7;&#x00131;nda&#x0011f; et al.</copyright-statement><copyright-year>2007</copyright-year><license license-type="open-access"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p><italic>Aims</italic>. To investigate serum leptin levels in Beh&#x000e7;et's patients with or without ocular involvement compared with healthy subjects and the relationship between serum leptin and uveitis activity in patients with ocular involvement. <italic>Methods</italic>. Fifty-seven patients with Beh&#x000e7;et's disease and 20 healthy control subjects were included in this study. While 27 patients had ocular involvement (18 had acute uveitis, 9 had inactive ocular involvement), 30 did not have ocular disease. C-reactive protein, alpha 1-antitrypsin, and serum leptin levels were measured in all samples. <italic>Results</italic>. There was a significant difference between the patients with Beh&#x000e7;et's disease and control group for both logarithm of leptin (<italic>P</italic> = .000) and logarithm of CRP (<italic>P</italic> = .031). Logarithm of leptin in non-ocular Beh&#x000e7;et's patients was significantly higher compared to its level in ocular Beh&#x000e7;et's disease and controls (<italic>P</italic> = .009). There was a significant difference between the patients with active ocular disease and control group (<italic>P</italic> = .03). <italic>Conclusions</italic>. Leptin might have a possible role in the pathogenesis of Beh&#x000e7;et's disease.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. INTRODUCTION</title><p>Beh&#x000e7;et's disease is a chronic, systemic inflammatory disorder affecting multiple organs with a generalized vasculitis [<xref ref-type="bibr" rid="B1">1</xref>]. The etiology and pathogenesis of Beh&#x000e7;et's disease have not been entirely enlightened. The main immunological features of Beh&#x000e7;et's disease consist of increased T- and B-cell responses to heat-shock proteins, increased neutrophil activity, and alterations in cytokine levels, although the interrelationships between and among these features have not been clarified [<xref ref-type="bibr" rid="B2">2</xref>]. Serum levels of neutrophil priming cytokines such as TNF, interleukin-1<italic>&#x003b2;</italic>, and IL-8 are determined to be raised in patients with Beh&#x000e7;et's disease [<xref ref-type="bibr" rid="B3">3</xref>].</p><p>Leptin is a peptide hormone that regulates body weight as well as endocrine and immune functions [<xref ref-type="bibr" rid="B4">4</xref>&#x02013;<xref ref-type="bibr" rid="B6">6</xref>]. Leptin has structural and functional similarities with members of cytokines family [<xref ref-type="bibr" rid="B7">7</xref>]. The leptin receptor is homologous to a subunit of the IL-6-type cytokine receptors [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>]. Leptin shares the same signal transduction pathway with cytokines [<xref ref-type="bibr" rid="B10">10</xref>].</p><p>In light of the fact that leptin might participate in the host response to inflammation, we aimed to investigate changes of serum leptin levels in Beh&#x000e7;et's patients with or without ocular involvement compared with healthy subjects and the relationship between serum leptin and uveitis activity in patients with ocular involvement. We compared serum leptin changes with other acute phase reactants, such as CRP or alpha-1 antitrypsin (<italic>&#x003b1;</italic>1-antitrypsin). </p></sec><sec sec-type="section" id="sec2"><title>2. MATERIAL AND METHODS</title><p>Fifty-seven patients with Beh&#x000e7;et's disease were included in this study. All patients included in the study met the international diagnostic criteria for Beh&#x000e7;et's disease [<xref ref-type="bibr" rid="B11">11</xref>]. A complete ophthalmologic examination was performed by ophthalmologists with an interest in Beh&#x000e7;et's disease. While 27 patients had ocular involvement, the other 30 did not have ocular disease. All patients with ocular involvement were split into two groups according to the activation of eye involvement to investigate the association between leptin levels and ocular disease activity. Of the 27 patients who had ocular disease, 18 suffered acute uveitis and 9 had inactive ocular involvement at the time of enrollment. None of the Beh&#x000e7;et's patients were on systemic steroids or immunosuppressant agents. Twenty healthy control subjects were also included in the study. The subjects who had any systemic or ocular disease were excluded. The subjects were matched for age, sex, and body mass index (BMI). Informed consent was obtained from all participants.</p><p>A venous blood sample was taken from each patient and control subject between 8.00 a.m. and 10:00 a.m. after an overnight fast. The blood samples were centrifugated to obtain serum. All serum samples were immediately stored at &#x02212;80&#x000b0;C until use.</p><p>C-reactive protein (CRP), <italic>&#x003b1;</italic>1-antitrypsin, and serum leptin levels were measured in all samples. C-reactive protein and <italic>&#x003b1;</italic>1-antitrypsin levels were measured by the immunoturbidimetric method using commercial kit (Roche Mannheim, Germany) on P 800 autoanalyzer (Roche). Serum samples were assayed for leptin, using enzyme-amplified sensitivity immunoassay kit (Biosource Europe S.A., Nivelles, Belgium).</p><p>Serum leptin levels were compared with those measurings of other acute phase reactants, such as CRP or <italic>&#x003b1;</italic>1-antitrypsin.</p><sec sec-type="subsection" id="subsec2.1"><title>2.1. Statistics</title><p>Statistical analysis was performed using SPSS 13.0 software for Windows. As the data were not normally distributed, logarithmic values of CRP (log CRP) and leptin (log leptin) levels were used. Statistical analysis was performed by Student <italic>t</italic> test to compare all Beh&#x000e7;et's patients with controls. ANOVA and post hoc test (Tukey HSD) were used to compare ocular Beh&#x000e7;et's patients with nonocular Beh&#x000e7;et's patients and controls. Kruskal-Wallis and Mann-Whitney <italic>U</italic> tests were used to compare active ocular Beh&#x000e7;et's patients with inactive ocular Beh&#x000e7;et's patients, nonocular Beh&#x000e7;et's patients, and controls.</p><p>Pearson's correlation test was used for evaluating the correlation between different parameters in all groups, apart from the group consisting of the patients with inactive eye involvement. Spearman's correlation analysis was used for evaluating that group. Data were presented as mean &#x000b1; SD. A value of <italic>P</italic> &#x0003c; .05 was considered significant.</p></sec></sec><sec sec-type="section" id="sec3"><title>3. RESULTS</title><p>Patient characteristics and laboratory findings are outlined in <xref ref-type="table" rid="T1">Table 1</xref>. Of the 57 patients in this study, 28 were male (49.1%) and 29 were female (50.9%). There was a significant difference between the patients with Beh&#x000e7;et's disease and control group for both log leptin (<italic>P</italic> = .000) and log CRP (<italic>P</italic> = .031). Log leptin in nonocular Beh&#x000e7;et's patients was significantly higher compared to its level in ocular Beh&#x000e7;et's disease and controls (<italic>P</italic> = .009). Log leptin was not different between patients with ocular and nonocular Beh&#x000e7;et's disease. However, there was a significant difference between the patients with active ocular Beh&#x000e7;et's disease and control group (<italic>P</italic> = .03).</p><p>In patients with Beh&#x000e7;et's disease, log leptin was correlated with BMI (<italic>r</italic> = .44, <italic>P</italic> = .001), and <italic>&#x003b1;</italic>1-antitrypsin was correlated with log CRP (<italic>r</italic> = .61, <italic>P</italic> = .000). On the other hand, there was no significant correlation between log leptin and <italic>&#x003b1;</italic>1-antitrypsin or log CRP. In patients with nonocular Beh&#x000e7;et's disease, <italic>&#x003b1;</italic>1-antitrypsin was correlated with log CRP (<italic>r</italic> = .56, <italic>P</italic> = .002), and log leptin was correlated with BMI (<italic>r</italic> = .052, <italic>P</italic> = .004). In patients with ocular Beh&#x000e7;et's disease, <italic>&#x003b1;</italic>1-antitrypsin was correlated with log CRP (<italic>r</italic> = .73, <italic>P</italic> = .000). In patients with active ocular Beh&#x000e7;et's disease, <italic>&#x003b1;</italic>1-antitrypsin was correlated with log CRP (<italic>r</italic> = .79, <italic>P</italic> = .000). In patients with inactive ocular Beh&#x000e7;et's disease, log leptin was correlated with BMI (<italic>r</italic> = .86, <italic>P</italic> = .007), and <italic>&#x003b1;</italic>1-antitrypsin was correlated with log CRP (<italic>r</italic> = .81, <italic>P</italic> = .014). In control group, there was no significant correlation between log leptin and <italic>&#x003b1;</italic>1-antitrypsin or BMI and log CRP.</p></sec><sec sec-type="section" id="sec4"><title>4. DISCUSSION</title><p>Leptin is primarily produced by adipose tissue. Leptin levels in the systemic circulation are controlled by a variety of factors, especially food intakeand the endocrine system [<xref ref-type="bibr" rid="B12">12</xref>]. The innate immune system also participates in the regulation of leptin production.</p><p>In experimental animals, leptin levels are acutely increased after administration of the inflammatory stimulus such as lipopolysaccharide (LPS) and turpentine, and proinflammatory cytokines such as tumor necrosis factor-<italic>&#x003b1;</italic> (TNF-<italic>&#x003b1;</italic>) and interleukin-1 (IL-1) [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B13">13</xref>]. The kinetics of leptinproduction during infectious and inflammatory processes is similar to that of cytokine induction [<xref ref-type="bibr" rid="B14">14</xref>].</p><p>Data obtained in human studies regarding the regulation of leptin expression in response to infection and inflammation are varied. The administration of IL-1<italic>&#x003b2;</italic> or TNF-<italic>&#x003b1;</italic> results in increased serum leptin levels in healthy subjects [<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>]. However, no increase in serum leptin levels was found after LPS injection to humans [<xref ref-type="bibr" rid="B17">17</xref>]. Leptin concentrations were found to be elevated during an acute inflammatory stimulus such as major surgery [<xref ref-type="bibr" rid="B18">18</xref>]. Nevertheless, in the chronic phase of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease, inflammation-associated leptin peaks were not observed [<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>].</p><p>Although the etiology and pathogenesis of Beh&#x000e7;et's disease are not clear, increased serum levels of inflammatory cytokines have been established to correlate with Beh&#x000e7;et's disease activity [<xref ref-type="bibr" rid="B3">3</xref>&#x02013;<xref ref-type="bibr" rid="B21">21</xref>]. A correlation between leptin levels and disease activity in patients with Beh&#x000e7;et's disease has been reported [<xref ref-type="bibr" rid="B22">22</xref>]. Leptin levels in 35 patients with Beh&#x000e7;et's disease were also found to be higher than in healthy controls in that study [<xref ref-type="bibr" rid="B22">22</xref>]. In another study, 28 males with ocular Beh&#x000e7;et's disease were compared with 15 healthy controls, and serum levels of leptin were not significantly different between the groups [<xref ref-type="bibr" rid="B23">23</xref>]. In that study, leptin levels were compared between patients with ocular Beh&#x000e7;et's disease and healthy subjects; whereas, we compared leptin levels between the groups composed of Beh&#x000e7;et's patients with and without ocular involvement and healthy subjects. In our study, patients with Beh&#x000e7;et's disease with or without ocular involvement were found to have higher serum leptin and CRP levels compared according to age-, sex-, and BMI-matched controls. However, in Beh&#x000e7;et's patients with ocular involvement, serum leptin concentrations were not significantly different from those in Beh&#x000e7;et's patients without ocular involvement in our study. The results of our study also demonstrated that the mean serum leptin levels were significantly increased in patients with active uveitis compared to control subjects.</p><p>Because serum leptin levels are closely associated with the amount of body fat and differ between males and females, BMI- and sex-matched subjects were enrolled in the groups. The subjects were on systemic steroids or immunosuppressive agents were not included in the study to avoid the possible effects of these agents on the serum leptin levels.</p><p>In conclusion, the higher serum leptin levels in patients with Beh&#x000e7;et's disease compared to control subjects in the present study might be attributed to a possible role for leptin in the pathogenesis of Beh&#x000e7;et's disease. Elevated serum leptin level does not seem to be a risk factor in ocular involvement. However, there might be a correlation between leptin levels and uveitis activity. Future studies would be useful to clarify the potential influence of leptin in Beh&#x000e7;et's disease.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We gratefully acknowledge the excellent technical assistance of Fato&#x0015f; &#x000d6;zyal&#x000e7;&#x00131;n and Emine Uluy&#x000fc;z.</p></ack><ref-list><ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rizzi</surname><given-names>R</given-names></name><name><surname>Bruno</surname><given-names>S</given-names></name><name><surname>Dammacco</surname><given-names>R</given-names></name></person-group><article-title>Beh&#x000e7;et's disease: an immune-mediated vasculitis involving vessels of all sizes</article-title><source><italic>International Journal of Clinical and Laboratory Research</italic></source><year>1997</year><volume>27</volume><issue>4</issue><fpage>225</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">9506265</pub-id></citation></ref><ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Al-Otaibi</surname><given-names>LM</given-names></name><name><surname>Porter</surname><given-names>SR</given-names></name><name><surname>Poate</surname><given-names>TWJ</given-names></name></person-group><article-title>Beh&#x000e7;et's disease: a review</article-title><source><italic>Journal of Dental Research</italic></source><year>2005</year><volume>84</volume><issue>3</issue><fpage>209</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">15723859</pub-id></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mege</surname><given-names>J-L</given-names></name><name><surname>Dilsen</surname><given-names>N</given-names></name><name><surname>Sanguedolce</surname><given-names>V</given-names></name><etal/></person-group><article-title>Overproduction of monocyte derived tumor necrosis factor <italic>&#x003b1;</italic>, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Beh&#x000e7;et's disease. A comparative study with familial Mediterranean fever and healthy subjects</article-title><source><italic>Journal of Rheumatology</italic></source><year>1993</year><volume>20</volume><issue>9</issue><fpage>1544</fpage><lpage>1549</lpage><pub-id pub-id-type="pmid">8164212</pub-id></citation></ref><ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahima</surname><given-names>RS</given-names></name><name><surname>Flier</surname><given-names>JS</given-names></name></person-group><article-title>Leptin</article-title><source><italic>Annual Review of Physiology</italic></source><year>2000</year><volume>62</volume><fpage>413</fpage><lpage>437</lpage></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fantuzzi</surname><given-names>G</given-names></name><name><surname>Faggioni</surname><given-names>R</given-names></name></person-group><article-title>Leptin in the regulation of immunity, inflammation, and hematopoiesis</article-title><source><italic>Journal of Leukocyte Biology</italic></source><year>2000</year><volume>68</volume><issue>4</issue><fpage>437</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">11037963</pub-id></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>G</given-names></name><name><surname>Gabay</surname><given-names>C</given-names></name></person-group><article-title>A role for leptin in rheumatic diseases?</article-title><source><italic>Annals of the Rheumatic Diseases</italic></source><year>2003</year><volume>62</volume><issue>10</issue><fpage>913</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">12972464</pub-id></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Basinski</surname><given-names>MB</given-names></name><name><surname>Beals</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Crystal structure of the obese protein leptin-E100</article-title><source><italic>Nature</italic></source><year>1997</year><volume>387</volume><issue>6629</issue><fpage>206</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">9144295</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tartaglia</surname><given-names>LA</given-names></name><name><surname>Dembski</surname><given-names>M</given-names></name><name><surname>Weng</surname><given-names>X</given-names></name><etal/></person-group><article-title>Identification and expression cloning of a leptin receptor, OB-R</article-title><source><italic>Cell</italic></source><year>1995</year><volume>83</volume><issue>7</issue><fpage>1263</fpage><lpage>1271</lpage><pub-id pub-id-type="pmid">8548812</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maruna</surname><given-names>P</given-names></name><name><surname>G&#x000fc;rlich</surname><given-names>R</given-names></name><name><surname>Fra&#x00161;ko</surname><given-names>R</given-names></name><name><surname>Haluz&#x000ed;k</surname><given-names>M</given-names></name></person-group><article-title>Serum leptin levels in septic men correlate well with C-reactive protein (CRP) and TNF-alpha but not with BMI</article-title><source><italic>Physiological Research</italic></source><year>2001</year><volume>50</volume><issue>6</issue><fpage>589</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">11829320</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baumann</surname><given-names>H</given-names></name><name><surname>Morella</surname><given-names>KK</given-names></name><name><surname>White</surname><given-names>DW</given-names></name><etal/></person-group><article-title>The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1996</year><volume>93</volume><issue>16</issue><fpage>8374</fpage><lpage>8378</lpage><pub-id pub-id-type="pmid">8710878</pub-id></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wechsler</surname><given-names>B</given-names></name><name><surname>Davatchi</surname><given-names>F</given-names></name><name><surname>Mizushima</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Criteria for diagnosis of Beh&#x000e7;et's disease</article-title><source><italic>Lancet</italic></source><year>1990</year><volume>335</volume><issue>8697</issue><fpage>1078</fpage><lpage>1080</lpage><pub-id pub-id-type="pmid">1970380</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>JM</given-names></name><name><surname>Halaas</surname><given-names>JL</given-names></name></person-group><article-title>Leptin and the regulation of body weight in mammals</article-title><source><italic>Nature</italic></source><year>1998</year><volume>395</volume><issue>6704</issue><fpage>763</fpage><lpage>770</lpage><pub-id pub-id-type="pmid">9796811</pub-id></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loffreda</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>SQ</given-names></name><name><surname>Lin</surname><given-names>HZ</given-names></name><etal/></person-group><article-title>Leptin regulates proinflammatory immune responses</article-title><source><italic>FASEB Journal</italic></source><year>1998</year><volume>12</volume><issue>1</issue><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">9438411</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarraf</surname><given-names>P</given-names></name><name><surname>Frederich</surname><given-names>RC</given-names></name><name><surname>Turner</surname><given-names>EM</given-names></name><etal/></person-group><article-title>Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia</article-title><source><italic>Journal of Experimental Medicine</italic></source><year>1997</year><volume>185</volume><issue>1</issue><fpage>171</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">8996253</pub-id></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Janik</surname><given-names>JE</given-names></name><name><surname>Curti</surname><given-names>BD</given-names></name><name><surname>Considine</surname><given-names>RV</given-names></name><etal/></person-group><article-title>Interleukin 1<italic>&#x003b1;</italic> increases serum leptin concentrations in humans</article-title><source><italic>Journal of Clinical Endocrinology and Metabolism</italic></source><year>1997</year><volume>82</volume><issue>9</issue><fpage>3084</fpage><lpage>3086</lpage><pub-id pub-id-type="pmid">9284748</pub-id></citation></ref><ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zumbach</surname><given-names>MS</given-names></name><name><surname>Boehme</surname><given-names>MWJ</given-names></name><name><surname>Wahl</surname><given-names>P</given-names></name><name><surname>Stremmel</surname><given-names>W</given-names></name><name><surname>Ziegler</surname><given-names>R</given-names></name><name><surname>Nawroth</surname><given-names>PP</given-names></name></person-group><article-title>Tumor necrosis factor increases serum leptin levels in humans</article-title><source><italic>Journal of Clinical Endocrinology and Metabolism</italic></source><year>1997</year><volume>82</volume><issue>12</issue><fpage>4080</fpage><lpage>4082</lpage><pub-id pub-id-type="pmid">9398717</pub-id></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bornstein</surname><given-names>SR</given-names></name><name><surname>Preas</surname><given-names>HL</given-names></name><name><surname>Chrousos</surname><given-names>GP</given-names></name><name><surname>Suffredini</surname><given-names>AF</given-names></name></person-group><article-title>Circulating leptin levels during acute experimental endotoxemia and antiinflammatory therapy in humans</article-title><source><italic>Journal of Infectious Diseases</italic></source><year>1998</year><volume>178</volume><issue>3</issue><fpage>887</fpage><lpage>890</lpage><pub-id pub-id-type="pmid">9728566</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>AM</given-names></name><name><surname>Sattar</surname><given-names>N</given-names></name><name><surname>McMillan</surname><given-names>DC</given-names></name></person-group><article-title>The coordinated cytokine/hormone response to acute injury incorporates leptin</article-title><source><italic>Cytokine</italic></source><year>2000</year><volume>12</volume><issue>7</issue><fpage>1042</fpage><lpage>1045</lpage><pub-id pub-id-type="pmid">10880250</pub-id></citation></ref><ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname><given-names>H-J</given-names></name><name><surname>Rihl</surname><given-names>M</given-names></name><name><surname>Heufelder</surname><given-names>A</given-names></name><name><surname>Loch</surname><given-names>O</given-names></name><name><surname>Schattenkirchner</surname><given-names>M</given-names></name></person-group><article-title>Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis</article-title><source><italic>Metabolism</italic></source><year>1999</year><volume>48</volume><issue>6</issue><fpage>745</fpage><lpage>748</lpage><pub-id pub-id-type="pmid">10381149</pub-id></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoppin</surname><given-names>AG</given-names></name><name><surname>Kaplan</surname><given-names>LM</given-names></name><name><surname>Zurakowski</surname><given-names>D</given-names></name><name><surname>Leichtner</surname><given-names>AM</given-names></name><name><surname>Bousvaros</surname><given-names>A</given-names></name></person-group><article-title>Serum leptin in children and young adults with inflammatory bowel disease</article-title><source><italic>Journal of Pediatric Gastroenterology and Nutrition</italic></source><year>1998</year><volume>26</volume><issue>5</issue><fpage>500</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">9586759</pub-id></citation></ref><ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turan</surname><given-names>B</given-names></name><name><surname>Gallati</surname><given-names>H</given-names></name><name><surname>Erdi</surname><given-names>H</given-names></name><name><surname>G&#x000fc;rler</surname><given-names>A</given-names></name><name><surname>Michel</surname><given-names>BA</given-names></name><name><surname>Villiger</surname><given-names>PM</given-names></name></person-group><article-title>Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Beh&#x000e7;et's disease; soluble TNFR-75 as a biological marker of disease activity</article-title><source><italic>Journal of Rheumatology</italic></source><year>1997</year><volume>24</volume><issue>1</issue><fpage>128</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">9002023</pub-id></citation></ref><ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evereklioglu</surname><given-names>C</given-names></name><name><surname>Inal&#x000f6;z</surname><given-names>HS</given-names></name><name><surname>Kirtak</surname><given-names>N</given-names></name><etal/></person-group><article-title>Serum leptin concentration is increased in patients with Beh&#x000e7;et's syndrome and is correlated with disease activity</article-title><source><italic>British Journal of Dermatology</italic></source><year>2002</year><volume>147</volume><issue>2</issue><fpage>331</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">12174107</pub-id></citation></ref><ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kavuncu</surname><given-names>S</given-names></name><name><surname>Ko&#x000e7;</surname><given-names>F</given-names></name><name><surname>Kurt</surname><given-names>M</given-names></name><etal/></person-group><article-title>Evaluation of serum leptin concentration in Beh&#x000e7;et's disease with ocular involvement</article-title><source><italic>Graefe's Archive for Clinical and Experimental Ophthalmology</italic></source><year>2005</year><volume>243</volume><issue>11</issue><fpage>1158</fpage><lpage>1160</lpage></citation></ref></ref-list></back><floats-wrap><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Patient demographics and laboratory findings in patients with ocular and nonocular Beh&#x000e7;et's disease and controls.</p></caption><table><tbody><tr><td rowspan="1" colspan="1"/><td colspan="5" align="center" rowspan="1">Patients with Beh&#x000e7;et's disease (BD)</td><td rowspan="2" align="center" colspan="1">Control subjects</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">All BD patients</td><td align="center" rowspan="1" colspan="1">Nonocular BD</td><td align="center" rowspan="1" colspan="1">All ocular BD</td><td align="center" rowspan="1" colspan="1">Active ocular BD</td><td align="center" rowspan="1" colspan="1">Inactive ocular BD</td></tr><tr><td colspan="7" rowspan="1"><hr/></td></tr><tr><td rowspan="1" colspan="1">Number</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">20</td></tr><tr><td rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">33.9 &#x000b1; 8.1</td><td align="center" rowspan="1" colspan="1">34.3 &#x000b1; 8.9</td><td align="center" rowspan="1" colspan="1">33.6 &#x000b1; 7.5</td><td align="center" rowspan="1" colspan="1">33.3 &#x000b1; 9</td><td align="center" rowspan="1" colspan="1">34.8 &#x000b1; 6.6</td><td align="center" rowspan="1" colspan="1">34.7 &#x000b1; 8.6</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">25.6 &#x000b1; 4.6</td><td align="center" rowspan="1" colspan="1">25.9 &#x000b1; 5.4</td><td align="center" rowspan="1" colspan="1">25.2 &#x000b1; 3.5</td><td align="center" rowspan="1" colspan="1">26 &#x000b1; 3.4</td><td align="center" rowspan="1" colspan="1">23.7 &#x000b1; 3.4</td><td align="center" rowspan="1" colspan="1">23.8 &#x000b1; 3.7</td></tr><tr><td rowspan="1" colspan="1">Log leptin (ng/mL)</td><td align="center" rowspan="1" colspan="1">1.9 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">2 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">1.9 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">1.9 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">1.9 &#x000b1; 0.3</td><td align="center" rowspan="1" colspan="1">1.7 &#x000b1; 0.1</td></tr><tr><td rowspan="1" colspan="1"><italic>&#x003b1;</italic>1-antitrypsin (mg/dL)</td><td align="center" rowspan="1" colspan="1">180.3 &#x000b1; 41.7</td><td align="center" rowspan="1" colspan="1">188.3 &#x000b1; 66.3</td><td align="center" rowspan="1" colspan="1">177.6 &#x000b1; 31.2</td><td align="center" rowspan="1" colspan="1">180.4 &#x000b1; 36.8</td><td align="center" rowspan="1" colspan="1">171.9 &#x000b1; 15.7</td><td align="center" rowspan="1" colspan="1">175.9 &#x000b1; 34.3</td></tr><tr><td rowspan="1" colspan="1">Log CRP (mg/L)</td><td align="center" rowspan="1" colspan="1">1.6 &#x000b1; 0.6</td><td align="center" rowspan="1" colspan="1">1.6 &#x000b1; 0.6</td><td align="center" rowspan="1" colspan="1">1.5 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">1.5 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">1.5 &#x000b1; 0.8</td><td align="center" rowspan="1" colspan="1">1.2 &#x000b1; 0.5</td></tr></tbody></table></table-wrap></floats-wrap></article> 